JAB-26766

N/A

Report date: 2025/09/19 20:01:00
NME

Base Information

Drug NameJAB-26766
Drug Alias NameJAB-26766
ClassificationSmall molecules
Mechanisms of ActionTCDD-inducible poly [ADP-ribose] polymerase inhibitors
TargetsTCDD-inducible poly [ADP-ribose] polymerase
Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaSquamous Cell Carcinoma of Head and Neck +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJacobio Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJacobio Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursSmall Cell Lung CarcinomaSquamous Cell Carcinoma of Head and Neck +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A